OnKure Therapeutics, Inc. (NASDAQ: OKUR) — Healthcare · Share Price, Chart & Market Data
About: OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.80 (-2.04%)
OKUROnKure Therapeutics, Inc.
Loading watchlist status…
Trade OKUR now
OnKure Therapeutics, Inc. share price
OKUR price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:40 pm GMT+0
OKUR price performance
-1.639%
5D
20.301%
1M
62.162%
YTD
88.976%
1Y
OKUR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:40 pm GMT+0
OKUR details
OKUR Market Signals